Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human gene marker/therapy clinical protocols.
Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Tiberghien P, et al. Rosenberg SA, et al. Among authors: tiberghien p. Hum Gene Ther. 1996 Dec 1;7(18):2287-313. doi: 10.1089/hum.1996.7.18-2287. Hum Gene Ther. 1996. PMID: 8953320 No abstract available.
Relevance of an academic GMP Pan-European vector infra-structure (PEVI).
Cohen-Haguenauer O, Creff N, Cruz P, Tunc C, Aïuti A, Baum C, Bosch F, Blomberg P, Cichutek K, Collins M, Danos O, Dehaut F, Federspiel M, Galun E, Garritsen H, Hauser H, Hildebrandt M, Klatzmann D, Merten OW, Montini E, O'Brien T, Panet A, Rasooly L, Scherman D, Schmidt M, Schweitzer M, Tiberghien P, Vandendriessche T, Ziehr H, Ylä-Herttuala S, von Kalle C, Gahrton G, Carrondo M. Cohen-Haguenauer O, et al. Among authors: tiberghien p. Curr Gene Ther. 2010 Dec;10(6):414-22. doi: 10.2174/156652310793797702. Curr Gene Ther. 2010. PMID: 21054249
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Le Voyer T, Bizien L, Manry J, Rosain J, Philippot Q, Goavec K, Padey B, Cupic A, Laurent E, Saker K, Vanker M, Särekannu K; COVID Human Genetic Effort; Etablissement Français du Sang Study Group; Constances Cohort; 3C-Dijon Study; Cerba HealthCare Group; Lyon Antigrippe Working Group; REIPI INF Working Group; García-Salum T, Ferres M, Le Corre N, Sánchez-Céspedes J, Balsera-Manzanero M, Carratala J, Retamar-Gentil P, Abelenda-Alonso G, Valiente A, Tiberghien P, Zins M, Debette S, Meyts I, Haerynck F, Castagnoli R, Notarangelo LD, Gonzalez-Granado LI, Dominguez-Pinilla N, Andreakos E, Triantafyllia V, Rodríguez-Gallego C, Solé-Violán J, Ruiz-Hernandez JJ, Rodríguez de Castro F, Ferreres J, Briones M, Wauters J, Vanderbeke L, Feys S, Kuo CY, Lei WT, Ku CL, Tal G, Etzioni A, Hanna S, Fournet T, Casalegno JS, Queromes G, Argaud L, Javouhey E, Rosa-Calatrava M, Cordero E, Aydillo T, Medina RA, Kisand K, Puel A, Jouanguy E, Abel L, Cobat A, Trouillet-Assant S, García-Sastre A, Casanova JL. Zhang Q, et al. Among authors: tiberghien p. J Exp Med. 2022 Nov 7;219(11):e20220514. doi: 10.1084/jem.20220514. Epub 2022 Sep 16. J Exp Med. 2022. PMID: 36112363 Free PMC article.
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.
Pommeret F, Colomba J, Bigenwald C, Laparra A, Bockel S, Bayle A, Michot JM, Hueso T, Albiges L, Tiberghien P, Marot S, Jary A, Lacombe K, Barlesi F, Griscelli F, Colomba E. Pommeret F, et al. Among authors: tiberghien p. Ann Oncol. 2021 Nov;32(11):1445-1447. doi: 10.1016/j.annonc.2021.07.015. Epub 2021 Aug 2. Ann Oncol. 2021. PMID: 34352377 Free PMC article. No abstract available.
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease.
Gervais A, Bastard P, Bizien L, Delifer C, Tiberghien P, Rodrigo C, Trespidi F, Angelini M, Rossini G, Lazzarotto T, Conti F, Cassaniti I, Baldanti F, Rovida F, Ferrari A, Mileto D, Mancon A, Abel L, Puel A, Cobat A, Rice CM, Cadar D, Schmidt-Chanasit J, Scheid JF, Lemieux JE, Rosenberg ES, Agudelo M, Tangye SG, Borghesi A, Durand GA, Duburcq-Gury E, Valencia BM, Lloyd AR, Nagy A, MacDonald MM, Simonin Y, Zhang SY, Casanova JL. Gervais A, et al. Among authors: tiberghien p. J Exp Med. 2024 Dec 2;221(12):e20240942. doi: 10.1084/jem.20240942. Epub 2024 Nov 1. J Exp Med. 2024. PMID: 39485284 Free PMC article.
Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom.
Mirrione-Savin A, Aghili Pour H, Swarbrick N, Müller S, Bacquet C, Malard L, Murphy MF, Richard P, Davies J, Rowley M, Poles D, Sandid I, Funk MB, Narayan S, Tiberghien P, Schäfer R. Mirrione-Savin A, et al. Among authors: tiberghien p. Br J Haematol. 2024 Oct 30. doi: 10.1111/bjh.19848. Online ahead of print. Br J Haematol. 2024. PMID: 39473331
Timing is essential: Humoral and cellular responses to SARS-CoV-2 vaccination in a cohort of patients with auto-immune diseases treated with rituximab.
Gallais Sérézal I, Spehner L, Kroemer M, Bourezane I, Meaux-Ruault N, Prati C, Pastissier A, Lodovichetti J, Tiberghien P, Aubin F. Gallais Sérézal I, et al. Among authors: tiberghien p. Heliyon. 2024 Sep 17;10(18):e38043. doi: 10.1016/j.heliyon.2024.e38043. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39328554 Free PMC article.
357 results